---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-130593"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2024-11-25T23:59:59+00:00"
generated_at: "2026-05-29T18:40:43.651299+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma sets 2025 annual meeting for Jan 30, 2025; record date Dec 9, 2024

## Summary
- 2025 Annual Meeting to be held on January 30, 2025.
- Stockholders of record as of December 9, 2024 entitled to vote.
- Deadline for Rule 14a-8 shareholder proposals is December 10, 2024.
- Deadline for director nominations outside Rule 14a-8 (Sept 18, 2024) has passed.

## SEC filing metadata
- accession: 0000950170-24-130593
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2024-11-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/0000950170-24-130593-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000095017024130593/meip-20241122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-130593
- JSON: https://secwatch.observer/filing/0000950170-24-130593.json
- Plain text: https://secwatch.observer/filing/0000950170-24-130593.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.